New Potential Treatment for Neurofibromatosis Type 1 Given Breakthrough Therapy Designation

A new medication called selumetinib has just received Breakthrough Therapy designation by the FDA for pediatric patients diagnosed with neurofibromatosis type 1 (NF1) or inoperable pleciform neurofibromas. This therapy has…

Continue Reading New Potential Treatment for Neurofibromatosis Type 1 Given Breakthrough Therapy Designation

Researchers are Working Hard to Understand GNAO1 Mutations: A Condition so Rare it Doesn’t Yet have a Name

"When only 100 people in the world share your child’s specific gene mutation, it is hard to find anyone who understands, including doctors." Rare diseases are at a disadvantage when…

Continue Reading Researchers are Working Hard to Understand GNAO1 Mutations: A Condition so Rare it Doesn’t Yet have a Name

The Struggles of being a Rare Disease Patient in China

The State of Rare Diseases in China The Illness Challenge Foundation (ICF) is an organization devoted to easing the burdens that rare disease patients living in China face. They accomplish this…

Continue Reading The Struggles of being a Rare Disease Patient in China

Phase 3 Study Shows Burosumab is Superior than Traditional Therapies for X-Linked Hypophosphatemia (XLH)

At the 2019 annual meeting of The Endocrine Society, ENDO 2019, results from a recent study evaluating burosumab for the treatment of X-linked hypophosphatemia (XLH) were presented. This drug was…

Continue Reading Phase 3 Study Shows Burosumab is Superior than Traditional Therapies for X-Linked Hypophosphatemia (XLH)
A Noninvasive Stool Test Could Identify Cirrhosis In Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
DarkoStojanovic / Pixabay

A Noninvasive Stool Test Could Identify Cirrhosis In Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Nonalcoholic fatty liver disease (NAFLD) is a condition in which the buildup of fat in the liver poses health concerns. Nonalcoholic Steatohepatitis (NASH) is a more severe, and more rare…

Continue Reading A Noninvasive Stool Test Could Identify Cirrhosis In Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Patient Worthy is Excited to Announce a New Partnership with The B.L.A.I.R. Connection!

A New Partnership Patient Worthy is honored and excited to announce our new partnership with The B.L.A.I.R. Connection. The B.L.A.I.R. Connection was founded by Grey Chapin who knows firsthand what…

Continue Reading Patient Worthy is Excited to Announce a New Partnership with The B.L.A.I.R. Connection!

Birth of Healthy Baby Monkey Indicates Promise of New Technique To Preserve Fertility of Childhood Cancer Patients

As the field of medicine has continually advanced, more and more children (now approximately 80%) are surviving cancer diagnoses. It's amazing. It also means that researchers are able to focus…

Continue Reading Birth of Healthy Baby Monkey Indicates Promise of New Technique To Preserve Fertility of Childhood Cancer Patients

New Potential Combination Therapy for Acute Myelogenous Leukemia has Received Breakthrough Therapy Designation

Acute Myelogenous Leukemia Acute myelogenous leukemia (AML) is a rare blood cancer whose prevalence increases with age. There are still extremely limited treatment options for AML and the five-year survival…

Continue Reading New Potential Combination Therapy for Acute Myelogenous Leukemia has Received Breakthrough Therapy Designation

Yet Another Study Shows the Dire Need for More Diversity in Medical Research

A recent study published in Cell has exhibited the scientific community's negligence for conducting research that includes an adequate representation of non-Europeans. Specifically, it showed that 78% of patients in genomic…

Continue Reading Yet Another Study Shows the Dire Need for More Diversity in Medical Research
Results from Three Clinical Trials for Urea Cycle Disorders and Cirrhosis Coming by the End of the Year
source: pixabay.com

Results from Three Clinical Trials for Urea Cycle Disorders and Cirrhosis Coming by the End of the Year

Three non-investigational New Drug clinical studies are underway for Urea Cycle Disorders (UCD) and various forms of cirrhosis, initiated by Kaleido Biosciences. Dosing has been initiated in each of these…

Continue Reading Results from Three Clinical Trials for Urea Cycle Disorders and Cirrhosis Coming by the End of the Year

Extremely Positive Results from Systemic Juvenile Idiopathic Arthritis 5-year Follow-Up Study in the EU

Extremely positive results have just been announced from a 5-year follow-up study of a systemic juvenile idiopathic arthritis (sJIA) treatment called Kineret. This treatment has been approved for use in…

Continue Reading Extremely Positive Results from Systemic Juvenile Idiopathic Arthritis 5-year Follow-Up Study in the EU